<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972018000300012</article-id>
<article-id pub-id-type="doi">10.26445/03.01.1</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estudio multicéntrico descriptivo de enfermedades pulmonares intersticiales asociadas a enfermedades autoinmunes en centros de salud en Montevideo, Uruguay.]]></article-title>
<article-title xml:lang="en"><![CDATA[Multicentric descriptive study of interstitial lung disease associated with autoimmune diseases in health centers in Montevideo, Uruguay.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Estudio multicêntrico descritivo de enfermarias pulmonares intersticiales asociadas a enfermedades autoinmunes en centros de saúde en Montevideo, Uruguay.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Cuña]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Consani]]></surname>
<given-names><![CDATA[Sandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[Fernanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Berez]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Clínica Médica Servicio Medicina Interna y de Enfermedades Autoinmunes]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Asociación Española de Socorro Mutuo Unidad de Enfermedades Autoinmunes ]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>3</volume>
<numero>3</numero>
<fpage>12</fpage>
<lpage>19</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972018000300012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972018000300012&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972018000300012&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  Las enfermedades pulmonares intersticiales (EPI) son una manifestación frecuente en algunas enfermedades autoinmune sistémica (EAIS). Objetivos: Describir las características de los pacientes que presentaron una EPI asociada a una EAIS, en centros de referencia de Montevideo. Valorar clínica, patrón imagenológico y severidad en pruebas de función respiratoria al momento diagnóstico.  Metodología:  Estudio multicéntrico descriptivo, observacional, de cohorte histórica, entre diciembre 2008 a diciembre 2017.  Resultados:  se enrolaron 59 pacientes, mujeres 88%, edad media 61 años. La clínica más frecuente fue la disnea. Las EAIS identificadas fueron: artritis reumatoidea (AR) 28%, esclerosis sistémica difusa (ESD) 22%, enfermedad mixta 6%, otras 42%. Debut con EPI previo a EAIS 9%; 47% presentó EPI en el primer año de diagnóstico de EAIS. Los patrones imagenológicos hallados fueron: neumonía intersticial no especifica (NINE) 64%, neumonía intersticial usual (NIU) 27%, neumonía organizativa 5%, neumonía intersticial linfoide 1%. Dentro del patrón NIU la enfermedad más prevalente fue la AR, en patrón NINE la ESD. La capacidad vital forzada (CVF) media fue de 80%, la DLCO media fue de 71%. En los pacientes con DLCO y CVF menor a 50% predominó la ESD.  Conclusiones: la AR y ESD fueron las EAIS más asociadas a EPI. El diagnostico de EPI se realizó durante el primer año del diagnóstico de la EAIS, siendo NINE el patrón imagenológico más frecuente. El patrón NIU fue el más prevalente en AR y NINE en ESD.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  The Interstitial Lung Disease (ILD) is a common manifestation from Connective Tisuue Disease (CTD). Objectives: Describe the characteristics of a population with ILD related to CTD in different hospitals of Montevideo. Analize the clinic manifestations, imagenologic pattern and severity of respiratory function evaluated by spirometry.  Methods:  Retrospective-descriptive of historical study of cohort, between 2008 december and december 2017.  Results:  59 patients were enrolled, female 88%, mean age 61.The first symptom in diagnosis was dyspnea. The CTD identified were: Rheumatoid Arthritis (AR) 28%, Sclerodermia (SL) 22%, Mixed-CTD 7%. Debut of ILD before CTD 9%. The 47% of de patients have ILD in the first year of de diagnosis. The imagenologic pattern were: non specific interstitial pneumonia (NSIP) 65%, usual interstitial pneumonia (UIP) 27%, organizing pneumonia 5%, lymphocytic interstitial pneumonia (LIP) 1%. The most common illness in UIP pattern was AR, in NINE was SL. Forced vital capacity (FVC) media was 80%, DLCO media 71%, SL predominate in patients with FVC and DLCO less than 50%.  Conclusions: AR and SL were the most common ILD. Almost half of the patients have ILD in the first year of the diagnosis, the NSIP pattern was the most frequent. UIP was most prevalent in AR and NSIP in SL.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  A doença pulmonar infecciosa intersticial (EPI) tem uma manifestação frequente em várias doenças auto-imunes sistêmicas (EAIS). Objetivos: Descrever as características dos doentes que apresentam uma EPI associada a uma EAIS, nos centros de referência de Montevideu. Valorar clínica, patologia imaginária e gravidade em provas de função respiratória no momento diagnóstico.  Metodología:  Estudio multicêntrico descritivo, observacional, de cohorte, diciembre de 2008 a diciembre 2017.  Resultados:  se enrolaron 59 pacientes, mujeres 88%, edad media 61 godina. A clínica mais frecuente fue la disnea. Las EAIS têm fueron: artrite reumatóide (AR) 28%, esclerose sistêmica difusa (ESD) 22%, enfermedad mixta 6%, otras 42%. Estréia com EPI previo a EAIS 9%; 47% presentó EPI no primer año de diagnóstico de EAIS. Los patrones imagenológicos hallados fueron: neumonía intersticial não especifica (NOVE) 64%, neumonía intersticial usual (NIU) 27%, neumonía organizativa 5%, neumonía intersticial linfoide 1%. Dentro do parque NIU a enfermaria mais prevalente fue la AR, en patrón NINE la ESD. A capacidade vital forçada (CVF) media de 80%, o DLCO media de 71%. Os pacientes com DLCO e CVF menor a 50% predominaram na ESD.  Conclusões:  la AR e ESD fueron las EAIS más asociadas a EPI. O diagnóstico de EPI realiza-se durante o primer ano do diagnóstico do EAIS, siendo NINE o patrón imagenológico mais frecuente. El patrón NIU fue el mais prevalente en AR y NINE en ESD.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedades autoinmunes sistémicas]]></kwd>
<kwd lng="es"><![CDATA[enfermedades de tejido conectivo]]></kwd>
<kwd lng="es"><![CDATA[enfermedades pulmonares intersticiales difusas]]></kwd>
<kwd lng="en"><![CDATA[Autoimmune disease]]></kwd>
<kwd lng="en"><![CDATA[connective tissue disease]]></kwd>
<kwd lng="en"><![CDATA[Interstitial lung disease]]></kwd>
<kwd lng="pt"><![CDATA[enfermedades autoinmunes sistémicas]]></kwd>
<kwd lng="pt"><![CDATA[enfermedades de tecido conectivo]]></kwd>
<kwd lng="pt"><![CDATA[enfermedades pulmonares intersticiales difusas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xaubet]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ancochea]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Blanquer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Montero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Morell]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Becerra]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales]]></article-title>
<source><![CDATA[Arch Bronco neumol]]></source>
<year>2003</year>
<volume>39</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>580-600</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bonilla]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones pulmonares de las enfermedades del colágeno]]></article-title>
<source><![CDATA[Arch Bronco neumol]]></source>
<year>2013</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>249-60</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathai]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Danoff]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of interstitial lung disease associated with connective tissue disease]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2016</year>
<volume>352</volume>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Saravanan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Nisar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arthanari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Woodhead]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Price-Forbes]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rheumatoid arthritis-related interstitial lung disease associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study]]></article-title>
<source><![CDATA[Rheumatology]]></source>
<year>2014</year>
<volume>53</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1676-82</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bussone]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mouthon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interstitial lung disease in systemic sclerosis]]></article-title>
<source><![CDATA[Autoimmunity Reviews]]></source>
<year>2011</year>
<volume>10</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>248-55</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gunnarsson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[El-Hage]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aalokken]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Reiseter]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lund]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Garen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Associations between anti- Ro52 antibodies and lung fibrosis in mixed connective tissue disease]]></article-title>
<source><![CDATA[Rheumatology (Oxford)]]></source>
<year>2016</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>103-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Romagnoli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nannini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Piciucchi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Girelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gurioli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Casoni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Idiopathic NSIP an interstitial lung disease associated with autoimmune disorders?]]></article-title>
<source><![CDATA[Eur Respir J]]></source>
<year>2011</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>384-91</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interstitial Lung Disease in Undifferentiated Forms of Connective Tissue Disease]]></article-title>
<source><![CDATA[Arthritis Care Res (Hoboken)]]></source>
<year>2015</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-11</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedades de sistema inmunitario, enfermedades autoinmunitarias, en: Robins y Cotran editores, Patología estructural y funcional]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rios]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Afectación pulmonar de las vasculitis]]></article-title>
<source><![CDATA[Arch Bronco neumol]]></source>
<year>2012</year>
<volume>48</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>410-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>American Thoracic Society.European Respiratory Society</collab>
<article-title xml:lang=""><![CDATA[American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2002</year>
<volume>165</volume>
<page-range>277-305</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mirfeizi]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Farrokh]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Javanbakht]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Raufi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chest High Resolution Computed Tomography Findings in Connective Tissue Diseases]]></article-title>
<source><![CDATA[Tanaffos]]></source>
<year>2013</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>49-52</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Dórame]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mejíaa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mateos-Toledoa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas-Serrano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rheumatoid arthritis-associated interstitial lung disease Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity]]></article-title>
<source><![CDATA[Reumatol Clin]]></source>
<year>2015</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical features of rheumatoid arthritis-associated interstitial lung disease]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2015</year>
<volume>5</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouros]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[AU]]></given-names>
</name>
<name>
<surname><![CDATA[Nicholson]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Colby]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Polychronopoulos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Pantelidis]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Histopathology subsets of fibrosingalveolitis in patients with systemic sclerosis and their relationship to outcome]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2002</year>
<volume>165</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1581-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kitaichi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nicholson]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Johkoh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Noma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary manifestations of primary Sjogren syndrome a clinical, radiological and pathologic study]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2005</year>
<volume>171</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>632-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
